Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
79.99
-1.38 (-1.70%)
Sep 1, 2026, 2:54 PM EDT - Market open

Globus Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
535.43537.87102.98122.87190.17149.19
Depreciation & Amortization
279.98276.84253.39145.5368.2569.87
Loss (Gain) From Sale of Assets
11.9512.535.551.540.30.46
Asset Writedown & Restructuring Costs
--12.61-0.1534.31
Loss (Gain) From Sale of Investments
----5.392.78
Stock-Based Compensation
48.9649.7854.1952.7432.8130.59
Provision & Write-off of Bad Debts
16.0710.2216.993.66-01.2
Other Operating Activities
120.95-67172.4833.76-13.345.13
Change in Accounts Receivable
-99.79-52.18-78.06-49.91-50.84-25.9
Change in Inventory
-50.43-17.6-29.86-70.33-61.75-11.97
Change in Accounts Payable
17.968.4917.66-14.2214.423.68
Change in Income Taxes
7.16-50.85-13.38-0.41-2.895.21
Change in Other Net Operating Assets
22.1445.356.0818.28-4.2111.72
Operating Cash Flow
910.39753.45520.64243.5178.47276.27
Operating Cash Flow Growth
36.05%44.72%113.81%36.44%-35.40%38.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-154.8-164.68-115.43-78.27-74.05-56.9
Cash Acquisitions
-1.41-252.55-17.64-296.03-31.44-34.49
Sale (Purchase) of Intangibles
-9.75-9.75----
Investment in Securities
-333.0671.96-42.99677.27-4.88-284.55
Investing Cash Flow
-499.01-355.01-176.05302.97-110.36-375.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--449.99----
Net Debt Issued (Repaid)
--449.99----
Issuance of Common Stock
110.7789.76110.4412.441.7263.5
Repurchase of Common Stock
-224.47-303.36-92.52-236.18-144.49-
Other Financing Activities
-21.43-15.57-45.62-8.04-7.19-9.35
Financing Cash Flow
-135.13-679.16-27.7-231.82-109.9654.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.0522.450.262.18-0.75-0.81
Net Cash Flow
278.3-258.28317.15316.83-42.6-46.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
755.59588.77405.21165.23104.42219.38
Free Cash Flow Growth
43.26%45.30%145.25%58.23%-52.40%62.34%
Free Cash Flow Margin
24.03%20.03%16.08%10.53%10.21%22.90%
Free Cash Flow Per Share
5.524.302.941.441.022.12
Levered Free Cash Flow
554.19327.53597.73-346.1375.52160.53
Unlevered Free Cash Flow
554.19327.53600.35-346.1375.52160.53

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
36.2998.92158.51100.5977.8245.03
Change in Working Capital
-102.95-66.8-97.55-116.6-105.26-17.25
SEC Filings: 10-K · 10-Q